Atezolizumab/Chemotherapy Approved by FDA in First-Line Treatment of Metastatic Lung Cancer
Case Studies: Possible Link Between Nivolumab for Lung Cancer and Pericardial Effusion
Final Overall Survival With Atezolizumab/Chemotherapy in Advanced Lung Cancer
Early Study Findings With Novel KRAS Inhibitor in Advanced Lung Cancers
Can BCG Vaccination During Childhood Reduce the Risk of Subsequent Lung Cancer?
First-in-Class Pegilodecakin Plus Immunotherapy Under Study in Lung Cancer
Bevacizumab Plus Erlotinib or Erlotinib Alone in EGFR-Mutated Lung Cancer
How Accurate Are Chest X-rays in Detecting Lung Cancer?
Proceedings from the 15th Annual Winter Lung Cancer Conference
Advanced Non-Small Cell Lung Ccancer Patient Management Simulator
An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care-Lung Cancer: Advanced Disease
UC San Diego Moores Cancer Center
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
City of Hope Comprehensive Cancer Center
Nivolumab in NSCLC
Lung Cancer Research Council, Inc.
Caring Ambassadors Program
Free to Breathe
NCCN Guidelines for Patients®